SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-675953
Filing Date
2016-08-09
Accepted
2016-08-09 06:46:58
Documents
54
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d183587d10q.htm 10-Q 657138
2 EX-31.1 d183587dex311.htm EX-31.1 6021
3 EX-31.2 d183587dex312.htm EX-31.2 5985
4 EX-32.1 d183587dex321.htm EX-32.1 4598
11 GRAPHIC g183587img001.jpg GRAPHIC 102162
  Complete submission text file 0001193125-16-675953.txt   3344513

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sage-20160630.xml EX-101.INS 513377
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20160630.xsd EX-101.SCH 41173
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20160630_cal.xml EX-101.CAL 44561
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20160630_def.xml EX-101.DEF 141458
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20160630_lab.xml EX-101.LAB 312900
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20160630_pre.xml EX-101.PRE 234097
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 161815996
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences